These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 19249520

  • 21. Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match.
    Avolio AW, Agnes S, Gasbarrini A, Nure E, Siciliano M, Castagneto M.
    Transplant Proc; 2006 May; 38(4):1059-62. PubMed ID: 16757263
    [Abstract] [Full Text] [Related]

  • 22. Impact of model for end-stage liver disease on patient survival and disease-free survival in patients receiving liver transplantation for hepatocellular carcinoma.
    Moonka D, Castillo E, Kumer S, Abouljoud M, Divine G, Pelletier S.
    Transplant Proc; 2009 May; 41(1):216-8. PubMed ID: 19249517
    [Abstract] [Full Text] [Related]

  • 23. Selection of pediatric candidates under the PELD system.
    McDiarmid SV, Merion RM, Dykstra DM, Harper AM.
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S23-30. PubMed ID: 15384170
    [Abstract] [Full Text] [Related]

  • 24. Regionwide sharing for status 1 liver patients--beneficial impact on waiting time and pre- and posttransplant survival.
    Humar A, Khwaja K, Glessing B, Larson E, Asolati M, Durand B, Lake J, Payne WD.
    Liver Transpl; 2004 May; 10(5):661-5. PubMed ID: 15108258
    [Abstract] [Full Text] [Related]

  • 25. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
    Ioannou GN, Perkins JD, Carithers RL.
    Gastroenterology; 2008 May; 134(5):1342-51. PubMed ID: 18471511
    [Abstract] [Full Text] [Related]

  • 26. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.
    Weismüller TJ, Negm A, Becker T, Barg-Hock H, Klempnauer J, Manns MP, Strassburg CP.
    Transpl Int; 2009 Oct; 22(10):970-8. PubMed ID: 19619170
    [Abstract] [Full Text] [Related]

  • 27. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
    Schaffer RL, Kulkarni S, Harper A, Millis JM, Cronin DC.
    Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
    [Abstract] [Full Text] [Related]

  • 28. Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis.
    Silberhumer GR, Pokorny H, Hetz H, Herkner H, Rasoul-Rockenschaub S, Soliman T, Wekerle T, Berlakovich GA, Steininger R, Muehlbacher F.
    Transplantation; 2007 Mar 15; 83(5):588-92. PubMed ID: 17353779
    [Abstract] [Full Text] [Related]

  • 29. Preliminary results of liver transplantation for hepatocellular carcinoma among allocation organ policy strategies, neoadjuvant treatments, and intention-to-treat analysis.
    Andorno E, Bottino G, Morelli N, Casaccia M, Gelli M, Piredda D, Immordino G, Ferrante R, Nardi I, Troilo BM, Di Domenico S, Ravazzoni F, Valente U.
    Transplant Proc; 2008 Mar 15; 40(6):1972-3. PubMed ID: 18675103
    [Abstract] [Full Text] [Related]

  • 30. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH, Hidalgo R, Thomé T, Melo VA, Lobue A, Zurstrassen MP, Moraes JM, Meira-Filho SP, Rezende MB, Fonseca LE, Pandullo FL, Soeiro FS, Afonso RC.
    Transplant Proc; 2007 Oct 15; 39(8):2511-3. PubMed ID: 17954160
    [Abstract] [Full Text] [Related]

  • 31. Liver transplant recipient selection: MELD vs. clinical judgment.
    Fink MA, Angus PW, Gow PJ, Berry SR, Wang BZ, Muralidharan V, Christophi C, Jones RM.
    Liver Transpl; 2005 Jun 15; 11(6):621-6. PubMed ID: 15915491
    [Abstract] [Full Text] [Related]

  • 32. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients.
    Barshes NR, Lee TC, Udell IW, O'mahoney CA, Karpen SJ, Carter BA, Goss JA.
    Liver Transpl; 2006 Mar 15; 12(3):475-80. PubMed ID: 16498644
    [Abstract] [Full Text] [Related]

  • 33. The impact of PELD on OPTN liver allocation: preliminary results.
    Davies DB.
    Clin Transpl; 2003 Mar 15; ():13-20. PubMed ID: 15387095
    [Abstract] [Full Text] [Related]

  • 34. Results of the first year of the new liver allocation plan.
    Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R, United Network for Organ Sharing Organ Procurement and Transplantation Network Liver and Transplantation Committee.
    Liver Transpl; 2004 Jan 15; 10(1):7-15. PubMed ID: 14755772
    [Abstract] [Full Text] [Related]

  • 35. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
    Austin MT, Poulose BK, Ray WA, Arbogast PG, Feurer ID, Pinson CW.
    Arch Surg; 2007 Nov 15; 142(11):1079-85. PubMed ID: 18025337
    [Abstract] [Full Text] [Related]

  • 36. Model for end-stage liver disease score-based allocation of donors for liver transplantation: a spanish multicenter experience.
    de la Mata M, Cuende N, Huet J, Bernardos A, Ferrón JA, Santoyo J, Pascasio JM, Rodrigo J, Solórzano G, Martín-Vivaldi R, Alonso M.
    Transplantation; 2006 Dec 15; 82(11):1429-35. PubMed ID: 17164713
    [Abstract] [Full Text] [Related]

  • 37. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep 15; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 38. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans.
    Ahmad J, Downey KK, Akoad M, Cacciarelli TV.
    Liver Transpl; 2007 Nov 15; 13(11):1564-9. PubMed ID: 17969210
    [Abstract] [Full Text] [Related]

  • 39. The new liver allocation system: moving toward evidence-based transplantation policy.
    Freeman RB, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, Merion R, Wolfe R, Turcotte J, Teperman L, UNOS/OPTN Liver Disease Severity Score, UNOS/OPTN Liver and Intestine, and UNOS/OPTN Pediatric Transplantation Committees.
    Liver Transpl; 2002 Sep 15; 8(9):851-8. PubMed ID: 12200791
    [Abstract] [Full Text] [Related]

  • 40. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.
    Liver Transpl; 2009 May 15; 15(5):496-503. PubMed ID: 19399732
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.